Advertisement

Topics

AbbVie Receives U.S. FDA Approval of MAVYRET™ (glecaprevir/pibrentasvir) for the Treatment of ...

15:28 EDT 3 Aug 2017 | BioMedReports - Blog

"With MAVYRET, physicians and patients now have a treatment option that is highly effective and has the potential to cure the majority of HCV patients

Read more...

Original Article: AbbVie Receives U.S. FDA Approval of MAVYRET™ (glecaprevir/pibrentasvir) for the Treatment of ...

NEXT ARTICLE

More From BioPortfolio on "AbbVie Receives U.S. FDA Approval of MAVYRET™ (glecaprevir/pibrentasvir) for the Treatment of ..."

Quick Search
Advertisement